TransMedics Group, Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $79.80
- 52-Week Range
- $60.11 – $156.00
- Market Cap
- $2.86B
- P/E (TTM)
- 21.41
- EPS (TTM)
- 3.86
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 5.52
- PEG Ratio
- 0.68
- Return on Equity
- 36.29%
- Return on Assets
- 4.33%
- Gross Margin
- 58.69%
- Operating Margin
- 12.50%
- Profit Margin
- 22.69%
- Current Ratio
- 6.63
- Debt/Equity
- 1.67
- Total Debt
- $867.72M
- Free Cash Flow
- $44.50M
- Revenue Growth
- 20.70%
- Earnings Growth
- -55.80%
- Enterprise Value
- $3.16B
Market Snapshot
About
TransMedics Group, Inc. is a medical technology company revolutionizing organ transplant therapy for end-stage organ failure patients. The company has developed the Organ Care System, a portable extracorporeal warm perfusion and assessment platform that maintains donor organs in a near-physiologic state outside the body.